Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., on efforts to promote and foster blood pathogen reduction technologies - FDA Press Releases

FDA statement on efforts to promote and foster blood pathogen reduction technologies

from Food and Drug Administration--Press Releases https://ift.tt/2HUmbW6
via IFTTT